Skip to main content

Swedish Research Council: Macchiarini, Karolinska Skipped Ethical Review

The federal agency publishes a brief note alleging another ethical breach by former Karolinska Institute researcher Paolo Macchiarini.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

WIKIMEDIA, IJNMIS01A Swedish law in place since January 2004 regarding research conducted on human beings (including living people, cadavers, biological material from people, and sensitive personal information) requires that investigators conducting such work apply for ethical review. According to Anna Hörnlund, chief legal counsel at the Swedish Research Council, neither former Karolinska Institute researcher Paolo Macchiarini nor his former institution submitted an application before conducting such research. “The Swedish Research Council considers Paolo Macchiarini's activities to be research conducted in human beings,” Hörnlund wrote in The Lancet last week (April 30).

Also last week (April 28), the Karolinska Institute announced that it is investigating concerns about Macchiarini and colleagues’ 2015 Respiration paper on the administration of an experimental cellular treatment on a patient with acute respiratory distress syndrome. “I received the case on my desk last week. We have analyzed it and will demand answers from the researchers involved,” Henrik Grönberg, pro-vice-chancellor of the Karolinska Institute, said in the statement. “After that, we will decide if we will submit the matter for external review.”

Some of Macchiarini’s coauthors on a 2011 The Lancet paper last month asked to have their names removed from that study. The Karonliska Institute terminated its contract with Macchiarini in March.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays